GLPBIO LAUNCHES A NEW THERAPEUTIC AGENT MCC950 SODIUM
LOS ANGELES, CALIFORNIA, UNITED STATES, November 1, 2022 /EINPresswire.com/ -- GlpBio, one of China's leading biotech companies, launches a new therapeutic agent MCC950 Sodium, which can be used in the treatment of autoimmune diseases and auto- …